Gastroenterologists treating patients with celiac disease face a difficult choice when deciding whether to biopsy. New European guidelines for pediatric patients suggest that serum markers and genetics are sufficient to confirm a diagnosis in many patients. U.S. guidelines still generally call for a biopsy to confirm the diagnosis.
Until the advent of corticosteroids and colectomy, nearly a third of inpatients with ulcerative colitis died of their disease. Even with effective treatments available, challenges remain in the medical and surgical management of these patients.
International experts will discuss different approaches to IBD during pregnancy, and how recent data may affect treatment decisions during Sunday’s AGA Clinical Symposium The Pregnant Patient with IBD: Data for an International Consensus?!
Learn all about the latest advances in IBD through a variety of scientific sessions at Digestive Disease Week® (DDW) 2017.